Category Archives: Parkinson’s Treatment

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/zw3772/disease_and) has announced the addition of the "Disease and Therapy Review: Parkinson's Disease" report to their offering. The Parkinson's Disease and Therapy Review provides an overview of the disease and related conditions, with incidence and prevalence numbers and percentages for major countries worldwide, information on diagnosis, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types. General information on the Parkinson's Disease market, as well as sales of leading drugs and therapies are provided. Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the author's senior market research team. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. Key Topics Covered: I. Overview Ii. Incidence And Prevalence Iii. … Continue reading →

Comic and actor Billy Connolly is being treated for the "initial symptoms" of Parkinson's Disease and has had surgery for prostate cancer. Sir Bob Geldof said his friend Billy Connolly is "as strong as an ox" and backed the comedian not to be deterred by the initial stages of Parkinson's disease and his surgery for prostate cancer. Sir Bob told Channel 5 News: "Pam [his wife] and Bill are great mates. Hes as strong as an ox mentally from everything hes been through as a kid. So I dont think this will deter him from being that individual that we know. Put simply Billy Connolly is a much loved comedy legend and we are sorry to hear that he is being treated for the early symptoms of Parkinson's. One person every hour will be diagnosed with Parkinson's in the UK, despite this it remains a little understood condition and we salute Billy's bravery in speaking out about his condition at this difficult time. There are 127,000 people in the UK, like Billy, living with Parkinson's. Parkinson's can be a very difficult condition to diagnose, as no two people with Parkinson's are the same, with symptoms - such a slowness of … Continue reading →

MONTREAL and EMERYVILLE, Calif., Oct. 2, 2013 /PRNewswire/ -- Adamas Pharmaceuticals, Inc. presented positive results today from the Phase 2/3 EASED clinical trial of ADS-5102 at the World Parkinson's Congress. ADS-5102 is Adamas' proprietary long-acting capsule formulation of amantadine HCl in development for the treatment of levodopa-induced dyskinesia (LID) in Parkinson's disease (PD) patients. ADS-5102 met its primary endpoint in the Phase 2/3 clinical trial and demonstrated statistically significant improvements in a number of key assessments of LID. (Logo: http://photos.prnewswire.com/prnh/20130618/LA33709LOGO) "We are extremely pleased with the positive results achieved in our Phase 2/3 EASED trial, and the magnitude of the change in ON time without troublesome dyskinesia in Parkinson's patients suffering from LID. Levodopa-induced dyskinesia is one of the most difficult challenges facing patients with PD, and there are no FDA-approved drug treatments available," said Gregory T. Went, Ph.D., Chief Executive Officer of Adamas. "ADS-5102 reduced both the duration and severity of dyskinesia among PD patients with statistical significance, providing an average of 11.5 hours during the day of ON time without troublesome dyskinesias as compared to 8 hours on placebo. The encouraging data from this trial indicate that ADS-5102 has the potential to positively impact the lives of PD … Continue reading →

From October 1-4, 2013 MONTREAL, Sept. 25, 2013 /CNW Telbec/ - If you're in Montreal at the beginning of October, chances are high that you will run into someone with Parkinson's. From October 1 to 4, Montreal will welcome the Parkinson's community when the city hosts the third World Parkinson Congress (WPC). More than 3,500 participants from over 60 countries are expected to attend this major event at the Palais des congrs, generating more than $6.4 million in economic spinoffs for our city. A great deal of effort has been put into making Montreal "Parkinson's ready" and now Montrealers are encouraged to welcome the delegates. As the only international forum that brings together world renowned neuroscientists, people living with Parkinson's, their caregivers, advocates, medical and healthcare professionals and dedicated researchers, the WPC requires years of preparation and collaboration between local and global organizations. In order to be ready to welcome such an important meeting and its delegates, many of whom live with Parkinson's disease, Tourisme Montral has worked hand in hand with Parkinson Society Qubec, Parkinson Society Canada, the World Parkinson Coalition and many other partners. Because the tourism industry, and front of house staff, is expected to have contact … Continue reading →

PHOENIX, Sept. 30, 2013 /PRNewswire/ --Millions around the nation recently watched the NBC premier of "The Michael J. Fox Show." Leading experts at the Muhammad Ali Parkinson Center in Phoenix say they are delighted to see national exposure for this often misunderstood disease. The new televisionseries stars Michael J. Fox as a news anchor who returns to work five years after being diagnosed with Parkinson's disease, which affects as many as 1.5 million Americans. "Our patients face many of the same life challenges as Michael J. Fox, so we are all excited to see him return to national television, bringing awareness to the disease," says Abraham Lieberman, MD, medical director of the Ali center. "Like Muhammad Ali, Michael J. Fox continues to be a champion for Parkinson's awareness and research." Parkinson's disease experts from the Ali center at St. Joseph's Barrow Neurological Institute in Phoenix are hopeful that Fox's character will both inspire patients and educate the general public about everyday struggles and successes for someone living with the disease. "It's important for a figure like Michael J. Fox to show the world that people diagnosed with Parkinson's disease can still live quality lives," says Arshia Sadreddin, MD, neurologist at … Continue reading →

6:20 a.m. EDT, September 30, 2013 NEW BRITAIN The Hospital for Special Care this month is launching a program for patients with Parkinson's disease and related disorders. Dr. Adam D. Simmons, a neurologist, will head the program, the hospital announced. "More than 1 million people have Parkinsons disease in the United States, and 50,000 to 60,000 new cases are diagnosed each year," the hospital said in a statement. "Parkinsons disease can affect gait, balance, flexibility, coordination, speech, voice and swallowing which affects activities of daily living and overall quality of life." Simmons said the hospital will treat all stages of the disease starting from onset. "We emphasize active patient involvement in their own care, to include exercise, physical therapy, medications, and lifestyle changes," he said The new program features the Lee Silverman Voice Treatment BIG and LOUD Program that was developed in 1987 and incorporates LOUD specialists in speech pathology and BIG-certified physical therapists. "With the LSVT LOUD, the muscles used for voice and speech are stimulated through a systematic hierarchy of exercises," the hospital said. "Treatment improves respiratory, laryngeal and articulatory function to improve speech intelligibility with improvements shown to last up to two years following treatment. Read the … Continue reading →

Home Mail News Sports Finance Weather Games Groups Answers Screen Flickr More omg! Shine Movies Music TV Health Shopping Travel Autos Homes Mobile Yahoo News Search News Search Web Sign In Mail Help Account Info Help Suggestions Yahoo News Home Video Photos GMA Year in Review Odd Comics Travel Opinion Trending Now Who Knew? Weather The Upbeat U.S. U.S. Video GMA Education Religion Crimes and Trials Local Contributor Network Year In Review World World Video Middle East Europe Latin America Africa Asia Canada Australia/Antarctica Business Video Exclusives Today's Markets Stocks Personal Finance Marketplace Entertainment Video Clinton Concert Celebrity TV Movies Music Fashion Books Arts Theater Dear Abby Comics Odd News Sports Video NFL MLB NBA NCAAF NCAAB Soccer Cycling NHL Tennis Golf Boxing Motor Sports MMA Olympics Tech Gadgets Wireless Apple Social Media Security Open Source Gaming Apps This Could Be Big Upgrade Your Life Politics Remake America The Issues Women and Politics Press Releases Video Science Science Video Weather News Space / Astronomy Pets Dinosaurs / Fossils Biotech Energy Green Health Video Weight Loss Cancer Sexual Health Medications/Drugs Parenting/Kids Seniors/Aging Diseases/Conditions Blogs The Sideshow Katie's Take Power Players This Could Be Big Newsmakers Trending Now The Upbeat Who Knew? … Continue reading →

KUSA - It was something Katie Strittmatter had done an untold number of times in her life: swallow her food and beverages. But on Memorial Day Weekend in 2010, all of a sudden, she couldn't do it anymore. "I had a neckache, and I just stopped swallowing. I couldn't swallow food or water," she said. Only 31 years old at the time, Strittmatter never thought the reason she couldn't control that function was because she had Parkinson's Disease. She was shocked at the news, and the way it was delivered. "I was alone when I was diagnosed," the mom-of-two who is now 34 years old said. "They hand you a prescription, and you're out." Strittmatter says, after telling her husband about the diagnosis over the phone, she didn't talk about her disease for a year. Thousands of people, though, can understand her story. "About 17,000 Coloradans are living with Parkinson's right now," Cheryl Siefert, Executive Director of Parkinson Association of the Rockies, said. The disease causes the brain to send incorrect messages to other parts of the body, causing muscles to either resist movement or move outside of a person's control. Strittmatter experiences everything from not being able to get … Continue reading →

HOUSTON - Glen Walber went to Houston Methodist Hospital looking for hope and relief from tremors caused by Parkinson's disease that kept him from sleeping and playing his beloved tennis. "When I had tremors I couldn't play tennis. I couldn't go on vacation. I couldn't go to San Antonio Fiesta Texas. I had a hard time sleeping because my body was moving at night and around Thanksgiving I couldn't even write my own name," said the computer programmer. "Watching him not be able to play tennis I think was the hardest part," said Judy Walber, his wife of 53 years. The 75-year-old decided to take a risk to regain his quality of life and underwent surgery for deep brain stimulation at Houston Methodist -- a surgical treatment proven to reduce some of the symptoms associated with Parkinson's disease. "First step we just put electrodes. Two weeks later we put a battery. He has a rechargeable battery basically that means it will last a long time and hopefully in his case a lifetime. He has a very small pacemaker-type device that controls both electrodes on both sides of the brain. The first procedure if everything goes right is a 1-day procedure … Continue reading →

Sep. 25, 2013 Parkinson disease, a neurodegenerative disorder in which both genetic and environmental factors play important roles, has been associated with epigenetic changes (those molecular modifications that alter the behavior of genes without changing the DNA sequence). Because accurate diagnosis is not easy for this disease, scientists are continuously trying to identify early signs of the disease that enable treatment before major neurological damage occurs. In an article published in the October issue of Epigenetics, those epigenetic changes appear to be great candidates as early stage biomarkers for Parkinson Disease. Researchers from UCSD have now shown that a distinctive pattern of epigenetic modifications (in this case called DNA methylation) is observed in specific genes associated with the disease. Even more interesting, these changes could be easily analyzed in blood samples from patients, which appear to replicate the "epigenetic status" of brain tissue cells, potentially simplifying early diagnosis of the disease. Share this story on Facebook, Twitter, and Google: Other social bookmarking and sharing tools: Story Source: The above story is based on materials provided by Landes Bioscience, via EurekAlert!, a service of AAAS. Note: Materials may be edited for content and length. For further information, please contact the source … Continue reading →